Rocket Pharmaceuticals, Inc.RCKTNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
6.51%
↑ 230% above average
Average (9y)
-5.01%
Historical baseline
Range
High:56.65%
Low:-127.15%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 6.51% |
| 2023 | 10.43% |
| 2022 | -21.64% |
| 2021 | -6.35% |
| 2020 | -48.24% |
| 2019 | 10.05% |
| 2018 | 56.65% |
| 2017 | 31.98% |
| 2016 | 37.71% |
| 2015 | -127.15% |